🏥Closed Meeting Notice - National Institutes of Health February 2024
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review contract proposals for vaccine adjuvant development. The meeting will take place on February 3-4, 2024, and focuses on confidentiality regarding trade secrets and personal information. It is not open to the public and serves an administrative purpose.
Learn More🧬Notice of Closed Meeting for Aging Research Grant Applications
The Department of Health and Human Services announces a closed meeting by the National Institute on Aging to review grant applications related to the impact of sex differences on Alzheimer's disease risk. The meeting's confidential nature protects sensitive information and trade secrets related to these applications, which is pertinent for stakeholders in the health and aging sectors.
Learn More💵NIH Grant Application Review Meetings - Business Opportunities
The National Institutes of Health announces upcoming closed meetings to evaluate and review grant applications related to heart, lung, and blood health research. These sessions are critical for assessing funding opportunities for research initiatives, especially for health-related businesses and organizations.
Learn More🏥NIH Meeting on Grants for Complementary Health Sector
The National Advisory Council for Complementary and Integrative Health will hold a closed meeting to evaluate grant applications. This meeting, which ensures confidentiality of discussed materials, emphasizes the importance of protecting sensitive information and trade secrets related to healthcare innovations in complementary and integrative health.
Learn More🔬Closed Meeting Notice for National Human Genome Research Grants
This notice announces a closed meeting of the National Human Genome Research Institute's Special Emphasis Panel to review grant applications. The meeting, set for April 30, 2025, will evaluate applications that may include confidential trade secrets and personal information, ensuring a closed format to protect sensitive data.
Learn More🧠NIH Neuroscience Grant Review Meetings Announcement
The Department of Health and Human Services announces closed meetings of the National Institute of Neurological Disorders and Stroke to evaluate grant applications. These meetings, which will be held virtually, focus on reviewing innovative proposals that may include confidential trade secrets and personal information. Contact information for committee members is provided for further inquiries.
Learn More🏥Notice of Closed Meeting at National Institute on Aging
The Department of Health and Human Services announces a closed meeting for the National Institute on Aging to review contract proposals. The meeting will focus on confidential discussions related to commercial property and personal privacy, and it will take place virtually on May 6, 2025. Interested parties can contact the Scientific Review Officer for further details.
Learn More🧬National Institute on Aging Meeting Notice
A notice from the Department of Health and Human Services regarding a closed meeting of the Board of Scientific Counselors at the National Institute on Aging. The meeting will focus on the review of grant applications and scientific evaluations for aging research, highlighting important discussions and deliberations pertaining to individual investigator qualifications and performance.
Learn More💰NIH Notice
The Department of Health and Human Services announces a closed meeting for the Eunice Kennedy Shriver National Institute of Child Health and Human Development, focusing on grant application evaluations. The meeting is set for April 15, 2025, and aims to discuss sensitive information that affects funding and research in pediatric health.
Learn More💉NIH Closed Meeting on Grant Applications for HIV Research
The Department of Health and Human Services has announced a closed meeting for the National Institute of Allergy and Infectious Diseases to review grant applications concerning HIV immunity research. The meeting aims to discuss confidential trade secrets and personal data, ensuring privacy during the evaluation process.
Learn More